Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Transorbent dressing (adhesive) 5cm x 7cm rectangular
20030600170
|
Transorbent dressing (adhesive) 5cm x 7cm rectangular | Wound Management & Other Dressings | Dressings | No data available |
|
Transparent Semi Permeable dressing LMJTD 9cm x 11cm
20030100202
|
Transparent Semi Permeable dressing LMJTD 9cm x 11cm | Wound Management & Other Dressings | Dressings | No data available |
|
Transpore tape 1.25cm
20100000730
|
Transpore tape 1.25cm | Surgical Adhesive Tape | Dressings | No data available |
|
Transurethral Catheter Safety System 12Ch-18Ch
21020001592
|
Transurethral Catheter Safety System 12Ch-18Ch | Catheters | Appliances | No data available |
|
Transvasin Heat spray
1003020T0BBABAF
|
Transvasin | Nicotinates | Musculoskeletal and Joint Diseases | No data available |
|
Tranxene 15mg capsules
0401020V0BBABAB
|
Tranxene | Clorazepate dipotassium | Central Nervous System | No data available |
|
Tranxene 7.5mg capsules
0401020V0BBAAAA
|
Tranxene | Clorazepate dipotassium | Central Nervous System | No data available |
|
Trapadex 37.5mg/325mg tablets
040702040BYAAAU
|
Trapadex | Tramadol hydrochloride | Central Nervous System | No data available |
|
Trasicor 20mg tablets
0204000N0BFAAAB
|
Trasicor | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Trasicor 40mg tablets
0204000N0BFABAC
|
Trasicor | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Trasicor 80mg tablets
0204000N0BFACAD
|
Trasicor | Oxprenolol hydrochloride | Cardiovascular System | No data available |
|
Trasidrex modified-release tablets
0204000Y0BBAAAA
|
Trasidrex | Co-prenozide (Oxprenolol hydrochloride/cyclopenthiazide) | Cardiovascular System | No data available |
|
Trastuzumab 150mg powder for solution for infusion vials
0801050ADAAAAAA
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 420mg powder for solution for infusion vials
0801050ADAAAEAE
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 600mg/5ml solution for injection vials
0801050ADAAABAB
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab 60mg powder for solution for infusion vials
0801050ADAAAFAF
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab emtansine 100mg inf vials
0801050ADAAACAC
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trastuzumab emtansine 160mg inf vials
0801050ADAAADAD
|
Trastuzumab | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
|
Trasylol 1,000,000 Kallikrein inactivator units/100ml inf
0211000H0BBAFAF
|
Trasylol | Aprotinin | Cardiovascular System | No data available |
|
Trasylol 2,000,000 Kallikrein inactivator units/200ml inf
0211000H0BBAGAG
|
Trasylol | Aprotinin | Cardiovascular System | No data available |
|
Trasylol 500,000 Kallikrein inactivator units/50ml inf vials
0211000H0BBAEAE
|
Trasylol | Aprotinin | Cardiovascular System | No data available |
|
Travel Calm 300microgram tablets
0406000L0BEABAT
|
Boots Travel Calm | Hyoscine hydrobromide | Central Nervous System | No data available |
|
Traveleeze Soft & Chewy pastilles
0406000N0BDAAAC
|
Traveleeze | Meclozine hydrochloride | Central Nervous System | No data available |
|
Traxam 3.17% foam
1003020M0BBABAB
|
Traxam | Felbinac | Musculoskeletal and Joint Diseases | No data available |
|
Trazimera 150mg pdr for concentrate for inf vials
0801050ADBGAAAA
|
Trazimera | Trastuzumab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.